Your browser doesn't support javascript.
loading
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.
Verbinnen, Iris; Monte-Boquet, Emilio; Parow, Detlev; Lacombe, Fabienne; Pothecary, Andrew; van Kuijk, Arno W R; Harrington, Laura; Müllerová, Edita; Pinter, Andreas; Erstling, Ulrike; Tomasini, Andrea; Helliwell, Philip S.
Afiliação
  • Verbinnen I; Laboratory of Protein Phosphorylation and Proteomics, Department of Cellular and Molecular Medicine, Leuven Brain Institute, University of Leuven, Leuven, Belgium.
  • Monte-Boquet E; Pharmacy Department, Drug Clinical Area, Hospital Universitari i Politècnic la Fe, Valencia, Spain.
  • Parow D; Formerly Department of Medicines, Therapeutic Appliances and Remedies, DAK-Gesundheit, Hamburg, Germany.
  • Lacombe F; Association France Spondyloarthrites, Tulle, France.
  • Pothecary A; Department of Rheumatology, Royal Cornwall Hospitals NHS Trust, Truro, UK.
  • van Kuijk AWR; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands.
  • Harrington L; Ogilvy Health, Oxford, UK.
  • Müllerová E; Revma Liga Ceská Republika, z.s., Prague, Czech Republic.
  • Pinter A; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
  • Erstling U; Fachverband Rheumatologische Fachassistenz e.V., Bergisch Gladbach, Germany.
  • Tomasini A; National Association of People with Rheumatological and Rare Diseases, APMARR, Lecce, Italy.
  • Helliwell PS; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. p.helliwell@leeds.ac.uk.
Rheumatol Ther ; 11(3): 795-815, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38662145
ABSTRACT

INTRODUCTION:

Psoriatic arthritis (PsA) is a complex, progressive, and often debilitating disease. Despite recent advances in treatment, numerous unmet needs in patient care persist. Rheumacensus is a multistakeholder, pan-European initiative designed to identify ways to elevate the standard of care (SoC) and treatment ambition for patients with PsA, using the perspectives of three key stakeholder groups patients, healthcare professionals (HCPs) and payors.

METHODS:

Rheumacensus followed three phases an insights-gathering workshop to identify current unmet needs in PsA and an area of focus for the project, a modified Delphi process to gain consensus on improvements within the agreed area of focus, and a Consensus Council (CC) meeting which used consensus statements as inspiration to generate 'Calls to Action' (CTA)-practical measures which, if implemented, could elevate the SoC for patients with PsA.

RESULTS:

The Rheumacensus CC consisted of four patient representatives, four HCPs and four payors. All 12 members completed all three Delphi e-consultations. The shared area of focus that informed the Delphi process was "patient empowerment through education on the disease and treatment options available, to enable patient involvement in management". Four key themes emerged from the Delphi process patient empowerment, patient knowledge and sources of education, patient-HCP consultations, and optimal initial treatment. Statements within these themes informed 12 overarching CTA, which focus on the need for a multistakeholder approach to implementing a paradigm shift towards patient-centred care and improved outcomes for patients with PsA.

CONCLUSION:

Rheumacensus has identified shortcomings in the current SoC for patients with PsA and provides a foundation for change through practical CTA. It is hoped that all stakeholders will now take practical steps towards implementing these CTA across Europe to elevate the SoC for patients with PsA.
Inequalities in the care patients with psoriatic arthritis (PsA) receive can be mainly explained by poorly coordinated management due to a lack of disease and treatment knowledge. This report is about a programme called Rheumacensus which has the overall aim of improving the standard of care (SoC) for patients with PsA. Rheumacensus brings together the points of view of three key groups involved in the care of people with PsA patients, payors and healthcare professionals (HCPs) from across Europe. Together, these three groups agreed to focus on patient empowerment through education on the disease and treatment options as a way to raise the SoC. Through a series of exercises­to agree on the current SoC and what needs to be improved­and group discussions, four themes were established which were used by the groups to help them suggest 'Calls to action' (CTA). The CTAs were ideas of how improvements could be made or what needs to be done to improve the care patients receive. The four themes were (1) patient empowerment, (2) patient knowledge, (3) patient­HCP consultation and (4) optimal initial treatment. In total, 12 CTAs were developed across these themes that provide direction and practical next steps which patients, payors and HCPs could take to drive change and make a real difference to patients by improving their care.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article